Erythropoietin - VeterinaryPartner.com - a VIN company!

news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.” View full resource at news-medical.net

Most Recently Shared on March 26, 2012 at 4:52 am By:

News-Medical.Net Health News

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia: Medgenics, Inc., the developer of... http://t.co/H0y4VuEt

4 weeks ago...

Retweet

Favorite

inVentiv Health announces launch of new European company

news-medical.net — “inVentiv Health, offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced the launch of inVentiv Health Communications/Europe, a new company that brings together inVentiv's advertising, public relations, public policy, market access, medical education, marketing, branding and digital services in a unified offering serving Europe.” View full resource at news-medical.net

Most Recently Shared on August 24, 2011 at 10:53 am By:

News-Medical.Net Health News

inVentiv Health announces launch of new European company: inVentiv Health, offering best-in-class clinical, comm... http://t.co/vinUrxT

8 months ago...

Retweet

Favorite

We Don't Have a Cure for Cancer Yet - or Do We?

articles.mercola.com — “The FDA shuts the door on almost every possible natural cure for cancer, like vitamin D, and favors toxic cancer treatments created by pharmaceutical companies.” View full resource at articles.mercola.com

Most Recently Shared on August 6, 2011 at 2:05 pm By:

Dr. Mercola Family Medicine Doctor, Physician, and Doctor

The Stunning Effect of This Single #Vitamin on #CANCER. Read more: http://ow.ly/5VIN7

9 months ago...

Retweet

Favorite

Medical News: Makers of Hand Sanitizers Slapped for MRSA Claims - in Infectious Disease, General Infectious Disease from MedPage Today

medpagetoday.com — “Four companies have been told to stop claiming their products prevent infection by methicillin-resistant Staphylococcus aureus (MRSA).” View full resource at medpagetoday.com

Most Recently Shared on April 20, 2011 at 9:00 pm By:

Jay Gordon, MD, FAAP Health Communicator, Physician, Doctor, and Pediatrician

RT @medpagetoday: Makers of hand sanitizers slapped for MRSA claims: http://bit.ly/eI5VIn

1 year ago...

Retweet

Favorite

ESC 2010 Congress: What's going to be hot | theheart.org

theheart.org — “Attendance at this year's ESC Congress in Stockholm is showing early signs of beating last year's record of 32000 attendees. This year's hot-line sessions, chosen from a record number of abstract submissions, include full details from the AVERROES trial of apixaban—top-line results of which were released early by the company—plus new randomized studies of ivabradine, erythropoietin in STEMI, and a long-term head-to-head comparison of two DES.” View full resource at theheart.org

Most Recently Shared on August 25, 2010 at 8:56 pm By:

James Rudd Doctor, Internist, Cardiologist, and Physician

#ESC10 preview from theheart.org http://www.theheart.org/article/1112393.do > watch out for my twitter coverage!

2 years ago...

Retweet

Favorite

What's Going to Be Hot at ESC 2010 Congress - QualityPoint Technologies

qualitypointtech.net — “This year's hot-line sessions, chosen from a record number of abstract submissions, include full details from the AVERROES trial of apixaban--top-line results of which were released early by the company--plus new randomized studies of ivabradine, erythropoietin in STEMI, and a long-term head-to-head comparison of two DES. Heartwire” View full resource at qualitypointtech.net